Edmond DE Rothschild Holding S.A. lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 45.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 555,165 shares of the company's stock after selling 467,004 shares during the period. Edmond DE Rothschild Holding S.A. owned about 0.30% of Doximity worth $29,640,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Thrivent Financial for Lutherans grew its holdings in shares of Doximity by 5.0% during the third quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company's stock worth $1,350,000 after purchasing an additional 1,474 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Doximity by 4.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company's stock worth $32,808,000 after buying an additional 31,966 shares during the period. Cerity Partners LLC raised its stake in Doximity by 21.4% during the third quarter. Cerity Partners LLC now owns 49,876 shares of the company's stock worth $2,173,000 after buying an additional 8,781 shares during the last quarter. FMR LLC grew its holdings in Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company's stock worth $297,920,000 after acquiring an additional 1,598,602 shares during the period. Finally, MetLife Investment Management LLC raised its position in shares of Doximity by 0.6% in the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock worth $2,835,000 after acquiring an additional 363 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.
Insider Activity
In related news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 37.40% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on DOCS shares. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Needham & Company LLC boosted their target price on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Stephens began coverage on shares of Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 target price on the stock. The Goldman Sachs Group lifted their price target on shares of Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, KeyCorp cut their price objective on shares of Doximity from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 8th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $64.22.
Check Out Our Latest Analysis on Doximity
Doximity Stock Up 2.2 %
NASDAQ:DOCS traded up $1.24 during trading hours on Wednesday, hitting $57.96. 1,819,929 shares of the company traded hands, compared to its average volume of 1,941,721. The company has a market cap of $10.82 billion, a PE ratio of 57.96, a PEG ratio of 4.10 and a beta of 1.34. The firm's 50-day simple moving average is $65.59 and its 200-day simple moving average is $54.81. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21.
Doximity Company Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.